Low-dose ALA had no significant effect on these proteins (Figure 7C,E–I), suggesting that ALA may alleviate DCM-induced ferritinophagy by activating the AMPK signaling pathway and inhibiting the expression of NCOA4 and SFXN1. The gene discussed is SFXN1; the disease is familial dilated cardiomyopathy.